Cargando…
Neoadjuvant denosumab for extensive giant cell tumor in os ischium —a case report
Autores principales: | van der Heijden, Lizz, van de Sande, Michiel A J, Hogendoorn, Pancras C W, Gelderblom, Hans, Dijkstra, P D Sander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443461/ https://www.ncbi.nlm.nih.gov/pubmed/25684041 http://dx.doi.org/10.3109/17453674.2014.1002345 |
Ejemplares similares
-
Adjuvant Zoledronic Acid in High‐Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial
por: Lipplaa, Astrid, et al.
Publicado: (2019) -
Challenges of denosumab in giant cell tumor of bone, and other giant cell-rich tumors of bone
por: Lipplaa, Astrid, et al.
Publicado: (2019) -
Malignant Transformation of Giant Cell Tumor of Bone and the Association with Denosumab Treatment: A Radiology and Pathology Perspective
por: van Langevelde, K., et al.
Publicado: (2022) -
Injuries and surgical diseases of the ischium
por: Milch, Henry, 1895-1964
Publicado: (1958) -
Soft tissue extension increases the risk of local recurrence after curettage with adjuvants for giant-cell tumor of the long bones: A retrospective study of 93 patients
por: van der Heijden, L, et al.
Publicado: (2012)